Combining exercise and dietary changes has a multiplicative effect on weight loss with a similar trend in lipids
n.a., not analyzed
Phase 3 data on retatrutide (triple GLP-1/GIP/glucagon agonist) showing nearly 29% weight loss, the pending approval of CagriSema (GLP-1/amylin combination), and the arrival of oral non-peptide GLP-1 agonists like orforglipron all suggest we are at the start of a metabolic therapeutics renaissance
In this blog, we will explore more about GLP-1 medications, such as their common GLP-1 agonist side effects, why they occur, and practical ways to manage them effectively
, 10 15 1,55 % (95 % 1,74 1,37) 1,57 % ( 1,76 1,37) HbA1c, 9,6 % ( 11,1 8,1) 11,6 % ( 13,0 10,1) [5]
How much does health insurance cost in Iowa